EP4578494A2 - Applying tumor treating fields (ttfields) via electrodes embedded into skull implants - Google Patents

Applying tumor treating fields (ttfields) via electrodes embedded into skull implants Download PDF

Info

Publication number
EP4578494A2
EP4578494A2 EP25177156.4A EP25177156A EP4578494A2 EP 4578494 A2 EP4578494 A2 EP 4578494A2 EP 25177156 A EP25177156 A EP 25177156A EP 4578494 A2 EP4578494 A2 EP 4578494A2
Authority
EP
European Patent Office
Prior art keywords
skull
electrodes
substrate
temperature sensor
implant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP25177156.4A
Other languages
German (de)
French (fr)
Other versions
EP4578494A3 (en
Inventor
Yoram Wasserman
Zeev Bomzon
Uri Weinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novocure GmbH
Original Assignee
Novocure GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novocure GmbH filed Critical Novocure GmbH
Publication of EP4578494A2 publication Critical patent/EP4578494A2/en
Publication of EP4578494A3 publication Critical patent/EP4578494A3/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0472Structure-related aspects
    • A61N1/0488Details about the lead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0529Electrodes for brain stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0529Electrodes for brain stimulation
    • A61N1/0539Anchoring of brain electrode systems, e.g. within burr hole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36002Cancer treatment, e.g. tumour
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals

Definitions

  • Tumor Treating Fields are low intensity (e.g., 1-3 V/cm) alternating electric fields within the intermediate frequency range (e.g., 100-500 kHz) that inhibit cancer cell growth.
  • This non-invasive treatment targets solid tumors and is described in US Patent 7,565,205 , which is incorporated herein by reference in its entirety.
  • 200 kHz TTFields are FDA approved for the treatment of glioblastoma (GBM), and may be delivered, for example, via the Optune TM system.
  • Optune TM includes a field generator and two pairs of transducer arrays (i.e., electrode arrays) that are placed on the patient's shaved head. One pair of arrays is positioned to the left and right of the tumor, and the other pair of arrays is positioned anterior and posterior to the tumor.
  • the first apparatus comprises a rigid substrate shaped and dimensioned to replace a section of a skull.
  • the substrate has an inner side and an outer side.
  • the first apparatus also comprises an electrically conductive plate having an inner side and an outer side. The outer side of the plate is affixed to the inner side of the substrate.
  • the first apparatus also comprises a dielectric layer disposed on the inner side of the plate; and an electrically conductive lead having an inner end and an outer end. The inner end of the lead is disposed in electrical contact with the plate, the lead passes through the substrate, and the outer end of the lead is configured to accept an electrical signal from an external device.
  • the first apparatus further comprise a temperature sensor positioned adjacent to the dielectric layer.
  • these embodiments may further comprise at least one wire that passes through the substrate and terminates at the temperature sensor, wherein the wire is configured to transmit an electrical signal from the temperature sensor to the external device.
  • the temperature sensor comprises a thermistor.
  • the dielectric layer comprises a ceramic layer with a dielectric constant of at least 10,000. In some embodiments of the first apparatus, the dielectric layer comprises a flexible thin layer of high dielectric polymer.
  • the second apparatus comprises a rigid substrate shaped and dimensioned to replace a section of a skull.
  • the substrate has an inner side and an outer side.
  • the second apparatus also comprises a plurality of electrically conductive plates, each having an inner side and an outer side. The outer side of each plate is affixed to the inner side of the substrate.
  • the second apparatus also comprises a dielectric layer disposed on the inner side of each plate; and a first electrically conductive lead having an inner end and an outer end. The inner end of the first lead is disposed in electrical contact with a first one of the plates, the first lead passes through the substrate, and the outer end of the first lead is configured to accept an electrical signal from an external device.
  • Some embodiments of the second apparatus further comprise a second electrically conductive lead having an inner end and an outer end.
  • the inner end of the second lead is disposed in electrical contact with a second one of the plates, the second lead passes through the substrate, and the outer end of the second lead is configured to accept an electrical signal from the external device.
  • Some embodiments of the second apparatus further comprise an additional electrically conductive lead disposed to electrically connect the first one of the plates with a second one of the plates.
  • the second apparatus further comprise a temperature sensor positioned adjacent to the dielectric layer.
  • these embodiments may further comprise at least one wire that passes through the substrate and terminates at the temperature sensor, wherein the wire is configured to transmit an electrical signal from the temperature sensor to the external device.
  • the temperature sensor comprises a thermistor.
  • the dielectric layer comprises a ceramic layer with a dielectric constant of at least 10,000. In some embodiments of the second apparatus, the dielectric layer comprises a flexible thin layer of high dielectric polymer.
  • Another aspect of the invention is directed to a first method of treating a tumor in a person's head.
  • the first method comprises positioning a first set of electrodes on an inner side of a first skull implant on a first side of the tumor; positioning a second set of electrodes on a second side of the tumor that is opposite to the first side; and applying an AC voltage between the first set of electrodes and the second set of electrodes to generate an alternating electric field that passes through the tumor.
  • the second set of electrodes is positioned on an inner side of the first skull implant. In some instances of the first method, the second set of electrodes is positioned on an inner side of a second skull implant. In some instances of the first method, the second set of electrodes is positioned on an exterior surface of the person's head.
  • the Optune TM transducer arrays In a patient with glioblastoma, when the Optune TM transducer arrays are positioned on a patient's shaved head, the electric field must pass through the patient's scalp and skull twice in order to reach the tumor.
  • This situation introduces two problems. First, the presence of the skull between the transducer array and the tumor makes it more difficult to aim the field at the desired location (i.e., the tumor bed) in the brain. And second, due to attenuation of the electric field introduced by the skull and scalp, the voltage and current that is applied to the transducer arrays must be relatively high (e.g., on the order of 50 VAC and on the order of 1 A) in order to obtain an electric field with a therapeutically effective magnitude in the tumor bed.
  • FIG. 1 depicts an embodiment that ameliorates both these problems by incorporating transducer arrays into one or more skull implants.
  • skull implants 10L and 10R are positioned on the left and right sides of the patient's skull 15, respectively; and skull implants 10A and 10P are positioned on the anterior and posterior sides of the patient's skull 15, respectively.
  • An AC field generator 11 applies an AC voltage between the electrodes in skull implant 10A and the electrodes in skull implant 10P for a first interval of time (e.g., 1 second); then (b) applies an AC voltage between the electrodes in skull implant 10L and the electrodes in skull implant 10R for a second interval of time (e.g., 1 second); then repeats that two-step sequence (a) and (b) for the duration of the treatment.
  • FIG. 2 depicts a first embodiment for implementing any one of the skull implants 10A/P/L/R depicted in FIG. 1 .
  • a rigid substrate 20 is shaped and dimensioned to replace a section of a skull.
  • the substrate 20 has an inner side and an outer side, and may be formed using any of a variety of conventional approaches for forming a skull implant (including but not limited to 3D printing).
  • the substrate 20 has an area of at least 5 cm 2 ,
  • An electrically conductive plate 22 is affixed to the inner side of the substrate 20.
  • This plate 22 is preferably metal (e.g., copper, steel, etc.), but alternative conductive materials may also be used.
  • the shape of the plate 22 may be customized to match the contours of the substrate 20, and the outer side of the plate 22 may be affixed to the substrate 20 using any of a variety of conventional approaches including but not limited to 3D printing and adhesives.
  • a dielectric layer 24 is disposed on the inner side of the plate 22.
  • the conductive plate 22 and the dielectric layer 24 form a capacitor, and using a higher capacitance improves the coupling of the electric field into the tumor.
  • One approach for achieving a high capacitance is to use a ceramic dielectric material with a dielectric constant of at least 10,000 for implementing the dielectric layer 24, similar to the approach used in the conventional Optune TM system.
  • An alternative approach for increasing the capacitance is to use a flexible thin layer of high dielectric polymer as the dielectric layer 24.
  • any portion of the conductive plate 22 that is not covered by the dielectric 24 should be covered by an appropriate insulator (e.g., medical grade silicone) to prevent non-capacitive coupling between the conductive plate 22 and tissue in the patient's head.
  • an appropriate insulator e.g., medical grade silicone
  • an electrically conductive lead 26 (e.g., a wire) is disposed in electrical contact with the plate 22.
  • the lead 26 passes through the substrate 20, and the outer end of the lead 26 is configured to accept an electrical signal from an external device (e.g., the field generator 11 depicted in FIG. 1 ). This may be accomplished, for example, by providing a terminal at the outer end of the lead 26.
  • the field generator 11 generates an AC voltage on the wires that lead to implant 10A and 10P, then generates an AC voltage on the wires that lead to implants 10L and 10R (in a repeating and alternating sequence as described above).
  • a corresponding AC current will travel through the wires 26 until it reaches the conductive plate 22 in each of the implants 10 A/B/L/R . Due to the presence of the dielectric layers 24, the desired electric field will be imposed in the tumor bed via capacitive coupling.
  • At least one temperature sensor e.g. a thermistor, not shown
  • a temperature sensor is integrated into each implant 10 A/P/L/R to reduce the risk of overheating any portion of the patient's brain.
  • appropriate wiring passes through the substrate 20 and is used to route the signal from the temperature sensor to the system's controller (which may be located, for example, in the field generator 11 shown in FIG. 1 ).
  • the system may be configured to communicate with the temperature sensor wirelessly using any of a variety of conventional approaches.
  • FIG. 3 is similar to the FIG. 2 embodiment, except that instead of using a single conductive plate 22 and a single dielectric layer 24 (as in the FIG. 2 embodiment), a plurality of smaller conductive plates 32 and smaller dielectric layers 34 are used.
  • each of these smaller conductive plates 32 may be round.
  • each of the smaller dielectric layers 34 may be a ceramic coating disposed on the smaller conductive plate 32.
  • a single lead 36 passes through the substrate 20 to one of the conductive plates 32, and internal wiring 37 is used to route the current to the other conductive plates.
  • the internal wiring may be omitted if each of the conductive plates 32 is provided with its own lead 36 that passes through the substrate 20.
  • the voltage and current used in this embodiment can be significantly lower than the voltage and current used in the conventional Optune TM system for any given desired field strength at the tumor. (This is because in the conventional Optune TM system, the electrodes are all positioned on the shaved scalp of the patient, which means that the electric field must traverse the scalp and skull twice to reach the tumor.)
  • transducer arrays when the transducer arrays are incorporated into skull implants, the planning of treatment so that the desired field appears in the tumor bed may be simplified because the electrical path between the transducer arrays on opposite sides of the tumor is simplified.
  • incorporating transducer arrays into skull implants can improve treatment planning in situations where the position of a surgical wound or skin abnormalities might prevent the application of conventional Optune TM transducer arrays to particular places on the surface of a patient's skin.
  • FIG. 1 depicts that all of the electrodes are incorporated into respective skull implants 10A/P/L/R. But in alternative embodiments, only some sets of electrodes are incorporated into a skull implant, and the remaining sets of electrodes are positioned outside the patient's skull (as in conventional TTFields treatment using Optune TM ). For example, one set of electrodes could be positioned in a skull implant 10A on the anterior side of the patient's head, and the sets of electrodes on the right, left, and posterior sides could all be positioned outside the patient's skull.
  • two or more sets of electrodes are incorporated into a single skull implant.
  • a single roughly hemispherical skull implant could be installed on a patient's head in place of the top hemisphere of the patient's skull, and all four sets of electrodes could be incorporated into that single skull implant (i.e., on the left, right, anterior, and posterior inner walls of the implant).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Electrotherapy Devices (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

Tumors inside a person's head (e.g., brain tumors) can be treated using tumor treating fields (TTFields) by positioning capacitively coupled electrodes on opposite sides of the tumor, and applying an AC voltage between the electrodes. Unlike the conventional approach (in which all of the electrodes are positioned on the person's scalp) at least one of the electrodes is implemented using an implanted apparatus. The implanted apparatus includes a rigid substrate shaped and dimensioned to replace a section of the person's skull. At least one electrically conductive plate is affixed to the inner side of the rigid substrate, and a dielectric layer is disposed on the inner side of the conductive plate or plates. An electrically conductive lead is used to apply an AC voltage to the conductive plate or plates.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This Application claims the benefit of US Provisional Application 62/880,893, filed July 31, 2019 , which is incorporated herein by reference in its entirety.
  • BACKGROUND
  • Tumor Treating Fields, or TTFields, are low intensity (e.g., 1-3 V/cm) alternating electric fields within the intermediate frequency range (e.g., 100-500 kHz) that inhibit cancer cell growth. This non-invasive treatment targets solid tumors and is described in US Patent 7,565,205 , which is incorporated herein by reference in its entirety. 200 kHz TTFields are FDA approved for the treatment of glioblastoma (GBM), and may be delivered, for example, via the Optune system. Optune includes a field generator and two pairs of transducer arrays (i.e., electrode arrays) that are placed on the patient's shaved head. One pair of arrays is positioned to the left and right of the tumor, and the other pair of arrays is positioned anterior and posterior to the tumor.
  • SUMMARY OF THE INVENTION
  • One aspect of the invention is directed to a first apparatus. The first apparatus comprises a rigid substrate shaped and dimensioned to replace a section of a skull. The substrate has an inner side and an outer side. The first apparatus also comprises an electrically conductive plate having an inner side and an outer side. The outer side of the plate is affixed to the inner side of the substrate. The first apparatus also comprises a dielectric layer disposed on the inner side of the plate; and an electrically conductive lead having an inner end and an outer end. The inner end of the lead is disposed in electrical contact with the plate, the lead passes through the substrate, and the outer end of the lead is configured to accept an electrical signal from an external device.
  • Some embodiments of the first apparatus further comprise a temperature sensor positioned adjacent to the dielectric layer. Optionally, these embodiments may further comprise at least one wire that passes through the substrate and terminates at the temperature sensor, wherein the wire is configured to transmit an electrical signal from the temperature sensor to the external device. Optionally, in these embodiments, the temperature sensor comprises a thermistor.
  • In some embodiments of the first apparatus, the dielectric layer comprises a ceramic layer with a dielectric constant of at least 10,000. In some embodiments of the first apparatus, the dielectric layer comprises a flexible thin layer of high dielectric polymer.
  • Another aspect of the invention is directed to a second apparatus. The second apparatus comprises a rigid substrate shaped and dimensioned to replace a section of a skull. The substrate has an inner side and an outer side. The second apparatus also comprises a plurality of electrically conductive plates, each having an inner side and an outer side. The outer side of each plate is affixed to the inner side of the substrate. The second apparatus also comprises a dielectric layer disposed on the inner side of each plate; and a first electrically conductive lead having an inner end and an outer end. The inner end of the first lead is disposed in electrical contact with a first one of the plates, the first lead passes through the substrate, and the outer end of the first lead is configured to accept an electrical signal from an external device.
  • Some embodiments of the second apparatus further comprise a second electrically conductive lead having an inner end and an outer end. The inner end of the second lead is disposed in electrical contact with a second one of the plates, the second lead passes through the substrate, and the outer end of the second lead is configured to accept an electrical signal from the external device.
  • Some embodiments of the second apparatus further comprise an additional electrically conductive lead disposed to electrically connect the first one of the plates with a second one of the plates.
  • Some embodiments of the second apparatus further comprise a temperature sensor positioned adjacent to the dielectric layer. Optionally, these embodiments may further comprise at least one wire that passes through the substrate and terminates at the temperature sensor, wherein the wire is configured to transmit an electrical signal from the temperature sensor to the external device. Optionally, in these embodiments, the temperature sensor comprises a thermistor.
  • In some embodiments of the second apparatus, the dielectric layer comprises a ceramic layer with a dielectric constant of at least 10,000. In some embodiments of the second apparatus, the dielectric layer comprises a flexible thin layer of high dielectric polymer.
  • Another aspect of the invention is directed to a first method of treating a tumor in a person's head. The first method comprises positioning a first set of electrodes on an inner side of a first skull implant on a first side of the tumor; positioning a second set of electrodes on a second side of the tumor that is opposite to the first side; and applying an AC voltage between the first set of electrodes and the second set of electrodes to generate an alternating electric field that passes through the tumor.
  • In some instances of the first method, the second set of electrodes is positioned on an inner side of the first skull implant. In some instances of the first method, the second set of electrodes is positioned on an inner side of a second skull implant. In some instances of the first method, the second set of electrodes is positioned on an exterior surface of the person's head.
  • BRIEF DESCRIPTION OF THE DRAWINGS
    • FIG. 1 depicts an embodiment that incorporates transducer arrays into four skull implants.
    • FIG. 2 depicts a first embodiment for implementing any one of the skull implants depicted in FIG. 1.
    • FIG. 3 depicts a second embodiment for implementing any one of the skull implants depicted in FIG. 1.
    • FIG. 4 depicts a third embodiment for implementing any one of the skull implants depicted in FIG. 1.
  • Various embodiments are described in detail below with reference to the accompanying drawings, wherein like reference numerals represent like elements.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • In a patient with glioblastoma, when the Optune transducer arrays are positioned on a patient's shaved head, the electric field must pass through the patient's scalp and skull twice in order to reach the tumor. This situation introduces two problems. First, the presence of the skull between the transducer array and the tumor makes it more difficult to aim the field at the desired location (i.e., the tumor bed) in the brain. And second, due to attenuation of the electric field introduced by the skull and scalp, the voltage and current that is applied to the transducer arrays must be relatively high (e.g., on the order of 50 VAC and on the order of 1 A) in order to obtain an electric field with a therapeutically effective magnitude in the tumor bed.
  • FIG. 1 depicts an embodiment that ameliorates both these problems by incorporating transducer arrays into one or more skull implants. In the illustrated embodiment, skull implants 10L and 10R are positioned on the left and right sides of the patient's skull 15, respectively; and skull implants 10A and 10P are positioned on the anterior and posterior sides of the patient's skull 15, respectively. An AC field generator 11 (a) applies an AC voltage between the electrodes in skull implant 10A and the electrodes in skull implant 10P for a first interval of time (e.g., 1 second); then (b) applies an AC voltage between the electrodes in skull implant 10L and the electrodes in skull implant 10R for a second interval of time (e.g., 1 second); then repeats that two-step sequence (a) and (b) for the duration of the treatment.
  • FIG. 2 depicts a first embodiment for implementing any one of the skull implants 10A/P/L/R depicted in FIG. 1. In this embodiment, a rigid substrate 20 is shaped and dimensioned to replace a section of a skull. The substrate 20 has an inner side and an outer side, and may be formed using any of a variety of conventional approaches for forming a skull implant (including but not limited to 3D printing). In some preferred embodiments, the substrate 20 has an area of at least 5 cm2,
  • An electrically conductive plate 22 is affixed to the inner side of the substrate 20. This plate 22 is preferably metal (e.g., copper, steel, etc.), but alternative conductive materials may also be used. The shape of the plate 22 may be customized to match the contours of the substrate 20, and the outer side of the plate 22 may be affixed to the substrate 20 using any of a variety of conventional approaches including but not limited to 3D printing and adhesives. A dielectric layer 24 is disposed on the inner side of the plate 22.
  • In many situations, it is preferable to capacitively coupled the electric field into the target region. The conductive plate 22 and the dielectric layer 24 form a capacitor, and using a higher capacitance improves the coupling of the electric field into the tumor. One approach for achieving a high capacitance is to use a ceramic dielectric material with a dielectric constant of at least 10,000 for implementing the dielectric layer 24, similar to the approach used in the conventional Optune system. An alternative approach for increasing the capacitance is to use a flexible thin layer of high dielectric polymer as the dielectric layer 24.
  • Any portion of the conductive plate 22 that is not covered by the dielectric 24 should be covered by an appropriate insulator (e.g., medical grade silicone) to prevent non-capacitive coupling between the conductive plate 22 and tissue in the patient's head.
  • The inner end of an electrically conductive lead 26 (e.g., a wire) is disposed in electrical contact with the plate 22. The lead 26 passes through the substrate 20, and the outer end of the lead 26 is configured to accept an electrical signal from an external device (e.g., the field generator 11 depicted in FIG. 1). This may be accomplished, for example, by providing a terminal at the outer end of the lead 26.
  • Assume, for example, that four sets of the apparatus 10 depicted in FIG. 2 are positioned on all four sides of the patient's head, (i.e., left, right, anterior, and posterior, respectively), as depicted in FIG. 1. The field generator 11 generates an AC voltage on the wires that lead to implant 10A and 10P, then generates an AC voltage on the wires that lead to implants 10L and 10R (in a repeating and alternating sequence as described above). A corresponding AC current will travel through the wires 26 until it reaches the conductive plate 22 in each of the implants 10 A/B/L/R. Due to the presence of the dielectric layers 24, the desired electric field will be imposed in the tumor bed via capacitive coupling.
  • Preferably, at least one temperature sensor (e.g. a thermistor, not shown) is integrated into each implant 10 A/P/L/R to reduce the risk of overheating any portion of the patient's brain. In some embodiments, appropriate wiring (not shown) passes through the substrate 20 and is used to route the signal from the temperature sensor to the system's controller (which may be located, for example, in the field generator 11 shown in FIG. 1). In alternative embodiments, the system may be configured to communicate with the temperature sensor wirelessly using any of a variety of conventional approaches.
  • FIG. 3 is similar to the FIG. 2 embodiment, except that instead of using a single conductive plate 22 and a single dielectric layer 24 (as in the FIG. 2 embodiment), a plurality of smaller conductive plates 32 and smaller dielectric layers 34 are used. Optionally, each of these smaller conductive plates 32 may be round. Optionally, each of the smaller dielectric layers 34 may be a ceramic coating disposed on the smaller conductive plate 32.
  • In the FIG. 3 embodiment, a single lead 36 passes through the substrate 20 to one of the conductive plates 32, and internal wiring 37 is used to route the current to the other conductive plates. Alternatively, as depicted in FIG. 4, the internal wiring may be omitted if each of the conductive plates 32 is provided with its own lead 36 that passes through the substrate 20.
  • Notably, since the electric field does not have to pass through the scalp or skull, the voltage and current used in this embodiment can be significantly lower than the voltage and current used in the conventional Optune system for any given desired field strength at the tumor. (This is because in the conventional Optune system, the electrodes are all positioned on the shaved scalp of the patient, which means that the electric field must traverse the scalp and skull twice to reach the tumor.)
  • In addition, when the transducer arrays are incorporated into skull implants, the planning of treatment so that the desired field appears in the tumor bed may be simplified because the electrical path between the transducer arrays on opposite sides of the tumor is simplified. Finally, incorporating transducer arrays into skull implants can improve treatment planning in situations where the position of a surgical wound or skin abnormalities might prevent the application of conventional Optune transducer arrays to particular places on the surface of a patient's skin.
  • Note that FIG. 1 depicts that all of the electrodes are incorporated into respective skull implants 10A/P/L/R. But in alternative embodiments, only some sets of electrodes are incorporated into a skull implant, and the remaining sets of electrodes are positioned outside the patient's skull (as in conventional TTFields treatment using Optune). For example, one set of electrodes could be positioned in a skull implant 10A on the anterior side of the patient's head, and the sets of electrodes on the right, left, and posterior sides could all be positioned outside the patient's skull.
  • In other alternative embodiments, two or more sets of electrodes are incorporated into a single skull implant. For example, a single roughly hemispherical skull implant could be installed on a patient's head in place of the top hemisphere of the patient's skull, and all four sets of electrodes could be incorporated into that single skull implant (i.e., on the left, right, anterior, and posterior inner walls of the implant).
  • While the present invention has been disclosed with reference to certain embodiments, numerous modifications, alterations, and changes to the described embodiments are possible without departing from the sphere and scope of the present invention, as defined in the appended claims. Accordingly, it is intended that the present invention not be limited to the described embodiments, but that it has the full scope defined by the language of the following claims, and equivalents thereof.
  • STATEMENTS
  • Furthermore, the present invention is represented by the following statements of invention.
    1. 1. An apparatus, comprising:
      • a rigid substrate shaped and dimensioned to replace a section of a skull, the substrate having an inner side and an outer side;
      • an electrically conductive plate having an inner side and an outer side, wherein the outer side of the plate is affixed to the inner side of the substrate;
      • a dielectric layer disposed on the inner side of the plate; and
      • an electrically conductive lead having an inner end and an outer end, wherein the inner end of the lead is disposed in electrical contact with the plate, wherein the lead passes through the substrate, and wherein the outer end of the lead is configured to accept an electrical signal from an external device.
    2. 2. The apparatus of statement 1, further comprising:
      a temperature sensor positioned adjacent to the dielectric layer.
    3. 3. The apparatus of statement 2, further comprising:
      at least one wire that passes through the substrate and terminates at the temperature sensor, wherein the wire is configured to transmit an electrical signal from the temperature sensor to the external device.
    4. 4. The apparatus of statement 3, wherein the temperature sensor comprises a thermistor.
    5. 5. The apparatus of statement 1, wherein the dielectric layer comprises a ceramic layer with a dielectric constant of at least 10,000.
    6. 6. The apparatus of statement 1, wherein the dielectric layer comprises a flexible thin layer of high dielectric polymer.
    7. 7. An apparatus, comprising:
      • a rigid substrate shaped and dimensioned to replace a section of a skull, the substrate having an inner side and an outer side;
      • a plurality of electrically conductive plates, each having an inner side and an outer side, wherein the outer side of each plate is affixed to the inner side of the substrate;
      • a dielectric layer disposed on the inner side of each plate; and
      • a first electrically conductive lead having an inner end and an outer end, wherein the inner end of the first lead is disposed in electrical contact with a first one of the plates, wherein the first lead passes through the substrate, and wherein the outer end of the first lead is configured to accept an electrical signal from an external device.
    8. 8. The apparatus of statement 7, further comprising:
      a second electrically conductive lead having an inner end and an outer end, wherein the inner end of the second lead is disposed in electrical contact with a second one of the plates, wherein the second lead passes through the substrate, and wherein the outer end of the second lead is configured to accept an electrical signal from the external device.
    9. 9. The apparatus of statement 7, further comprising:
      an additional electrically conductive lead disposed to electrically connect the first one of the plates with a second one of the plates.
    10. 10. The apparatus of statement 7, further comprising:
      a temperature sensor positioned adjacent to the dielectric layer.
    11. 11. The apparatus of statement 10, further comprising:
      at least one wire that passes through the substrate and terminates at the temperature sensor, wherein the wire is configured to transmit an electrical signal from the temperature sensor to the external device.
    12. 12. The apparatus of statement 11, wherein the temperature sensor comprises a thermistor.
    13. 13. The apparatus of statement 7, wherein the dielectric layer comprises a ceramic layer with a dielectric constant of at least 10,000.
    14. 14. The apparatus of statement 7, wherein the dielectric layer comprises a flexible thin layer of high dielectric polymer.
    15. 15. A method of treating a tumor in a person's head, the method comprising:
      • positioning a first set of electrodes on an inner side of a first skull implant on a first side of the tumor;
      • positioning a second set of electrodes on a second side of the tumor that is opposite to the first side; and
      • applying an AC voltage between the first set of electrodes and the second set of electrodes to generate an alternating electric field that passes through the tumor.
    16. 16. The method of statement 15, wherein the second set of electrodes is positioned on an inner side of the first skull implant.
    17. 17. The method of statement 15, wherein the second set of electrodes is positioned on an inner side of a second skull implant.
    18. 18. The method of statement 15, wherein the second set of electrodes is positioned on an exterior surface of the person's head.

Claims (15)

  1. A system for treating a tumor or tumor bed in a patient's head, comprising:
    one or more skull implants (10L, 10R, 10A, 10P), each incorporating a transducer array comprising at least one electrode; and
    a field generator (11) configured to generate an AC voltage on wires that lead to the one or more skull implants (10L, 10R, 10A, 10P).
  2. The system of claim 1, further comprising:
    at least one temperature sensor integrated into each skull implant (10L, 10R, 10A, 10P).
  3. The system of claim 2, wherein the at least one temperature sensor is configured to communicate wirelessly.
  4. The system of claim 1, wherein the one or more skull implants (10L, 10R, 10A, 10P) each comprise a substrate (20) shaped and dimensioned to replace a section of a skull, with the substrate (20) having an inner side and an outer side.
  5. The system of claim 4, wherein the substrate (20) has an area of at least 5 cm2.
  6. The system of claim 4, further comprising:
    a controller;
    at least one temperature sensor integrated into each skull implant (10L, 10R, 10A, 10P); and
    wiring passing through the substrate (20) to route a signal from the at least one temperature sensor to the controller.
  7. The system of claim 6, wherein the controller is located in the field generator (11).
  8. The system of claim 2 or 6, wherein the at least one temperature sensor comprises a thermistor.
  9. The system of claim 1, wherein the at least one electrode comprises an electrically-conductive plate (22), having an inner side and an outer side, and the outer side of each plate (22) is affixed to the inner side of the substrate (20).
  10. The system of claim 9, wherein the at least one electrode comprises a dielectric layer (24) disposed on the inner side of the plate (22).
  11. The system of claim 10, wherein the dielectric layer (24) is a ceramic with a dielectric constant of at least 10,000 or a flexible thin layer of high dielectric polymer.
  12. The system of claim 1, comprising:
    a single skull implant (10L, 10R, 10A, 10P).
  13. The system of claim 12, wherein the skull implant (10L, 10R, 10A, 10P) is hemispherical.
  14. The system of claim 1, wherein all electrodes of the system are incorporated into the at least one skull implant (10L, 10R, 10A, 10P).
  15. The system of claim 1, wherein electrodes incorporated into the at least one skull implant (10L, 10R, 10A, 10P) represent some of the electrodes of the system, and further comprising:
    electrodes positionable outside the patient's skull.
EP25177156.4A 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants Pending EP4578494A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962880893P 2019-07-31 2019-07-31
PCT/IB2020/057022 WO2021019403A1 (en) 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
EP20751294.8A EP4003492B1 (en) 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP20751294.8A Division EP4003492B1 (en) 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
EP20751294.8A Division-Into EP4003492B1 (en) 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants

Publications (2)

Publication Number Publication Date
EP4578494A2 true EP4578494A2 (en) 2025-07-02
EP4578494A3 EP4578494A3 (en) 2025-07-30

Family

ID=71948633

Family Applications (3)

Application Number Title Priority Date Filing Date
EP20751294.8A Active EP4003492B1 (en) 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
EP22180751.4A Active EP4085967B1 (en) 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
EP25177156.4A Pending EP4578494A3 (en) 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP20751294.8A Active EP4003492B1 (en) 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
EP22180751.4A Active EP4085967B1 (en) 2019-07-31 2020-07-24 Applying tumor treating fields (ttfields) via electrodes embedded into skull implants

Country Status (5)

Country Link
US (3) US11654279B2 (en)
EP (3) EP4003492B1 (en)
JP (2) JP7472264B2 (en)
CN (2) CN114364432B (en)
WO (1) WO2021019403A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180001075A1 (en) 2016-06-30 2018-01-04 Novocure Limited Arrays for Longitudinal Delivery of TTFields to a Body
US11986647B2 (en) 2018-09-07 2024-05-21 Novocure Gmbh Treating autoinflammatory and mitochondrial diseases using an alternating electric field
EP3984590B1 (en) 2018-10-15 2022-12-07 Novocure GmbH Generating tumor treating fields (ttfields) with high uniformity throughout the brain
JP7148722B2 (en) 2018-10-25 2022-10-05 ゼーヴ・ボンゾン Delivery of an alternating electric field (e.g., TTField) to the spinal structures of a subject
SG11202101810SA (en) 2018-11-29 2021-03-30 Novocure Gmbh Enhanced-flexibility transducer arrays for delivering ttfields (tumor treating fields)
EP3961565A1 (en) 2019-01-08 2022-03-02 Novocure GmbH Evaluating quality of segmentation of an image into different types of tissue for planning treatment using tumor treating fields (ttfields)
US11291837B2 (en) 2019-04-17 2022-04-05 Novocure Gmbh Uploading data from an isolated system without compromising isolation
ES2950234T3 (en) 2019-12-31 2023-10-06 Novocure Gmbh Arrays for delivering tumor treatment fields (TT fields) with individually accessible electrode elements and temperature sensors
EP4091665B1 (en) 2019-12-31 2024-10-30 Novocure GmbH High voltage, high efficiency sine wave generator that prevents spikes during amplitude adjustments and switching of channels
US20210299440A1 (en) 2020-03-30 2021-09-30 Novocure Gmbh Intravenous / Intra-Spinal / Intra-Cavity / Intraventricular Delivery of TTFields (Tumor Treating Fields) for Treating Cancer and Metastases
BR112022021484A2 (en) 2020-04-24 2022-12-13 Novocure Gmbh USE OF ALTERNATING ELECTRIC FIELDS TO INCREASE THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER
US11818943B2 (en) 2020-06-25 2023-11-14 Novocure Gmbh Fabricating organic light emitting diodes (OLEDs) using tubulin
JP7777118B2 (en) 2020-09-25 2025-11-27 ノボキュア ゲーエムベーハー Varying the metallization coverage of individual electrode elements in the tumor treating field (TTField) to maximize current flow without overheating
CN113008403B (en) * 2021-02-08 2022-08-12 清华大学 Electric field generating device and temperature measuring electrode device
EP4240470A1 (en) 2021-02-17 2023-09-13 Novocure Gmbh Arrays for delivering tumor treating fields (ttfields) with sets of electrode elements having individually adjustable active areas
US12440680B2 (en) 2021-03-12 2025-10-14 Novocure Gmbh Methods of treating disease by skewing macrophage phenotype with alternating electric fields
EP4284489B1 (en) 2021-03-31 2025-07-16 Novocure Gmbh Impedance tomography using electrodes of a tumor treating fields (ttfields) system
CN113101517B (en) * 2021-04-15 2022-02-01 中国医学科学院北京协和医院 Implantable electrode device and preparation method thereof
KR20240027008A (en) 2021-06-30 2024-02-29 노보큐어 게엠베하 Use of capacitors to limit current in a transducer array to apply a tumor treatment field (TTFIELD)
US12599765B2 (en) 2021-12-14 2026-04-14 Novocure Gmbh Shifting of transducer array to reduce skin irritation
WO2023126842A1 (en) 2021-12-29 2023-07-06 Novocure Gmbh Apparatus for reducing electrosensation using alternating electric fields with larger cathodes and smaller anodes
EP4456971A1 (en) 2021-12-30 2024-11-06 Novocure GmbH Selecting values of parameters for treatment using tumor treating fields (ttfields)
CN114225215B (en) * 2021-12-31 2023-05-05 湖南安泰康成生物科技有限公司 Electrode system
EP4460361B1 (en) 2022-03-30 2025-03-19 Novocure GmbH Using interleaved cooling periods to increase the peak intensity of tumor treating fields
US12478793B2 (en) 2022-03-30 2025-11-25 Novocure Gmbh Reducing electrosensation whilst treating a subject using alternating electric fields by pairing transducer arrays together
WO2024119097A1 (en) * 2022-12-01 2024-06-06 Mayo Foundation For Medical Education And Research Brain implant devices and methods
US12268863B2 (en) 2023-02-06 2025-04-08 Novocure Gmbh Shiftable transducer array with anisotropic material layer
WO2025068942A1 (en) 2023-09-29 2025-04-03 Novocure Gmbh Delivering tumor treating fields (ttfields) to a subject's brain using electrodes installed in through-holes in the subject's skull
CN121925295A (en) 2023-09-29 2026-04-24 诺沃库勒有限责任公司 Using alternating variations in amplitude and frequency to improve electrosensory sensation during therapy with alternating electric fields.
ES2967801A1 (en) * 2023-12-22 2024-05-03 Univ Madrid Politecnica Implant device for treatment of pathologies using electric fields (Machine-translation by Google Translate, not legally binding)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7565205B2 (en) 2000-02-17 2009-07-21 Standen Ltd. Treating a tumor or the like with electric fields at different orientations

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5983141A (en) * 1996-06-27 1999-11-09 Radionics, Inc. Method and apparatus for altering neural tissue function
US8447395B2 (en) 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
EP2335776A1 (en) 2000-02-17 2011-06-22 Yoram Palti Method and apparatus for destroying dividing cells
US6868289B2 (en) 2002-10-02 2005-03-15 Standen Ltd. Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor
US7089054B2 (en) 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
US7136699B2 (en) 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
US7016725B2 (en) 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
US20030125786A1 (en) * 2000-07-13 2003-07-03 Gliner Bradford Evan Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7010351B2 (en) * 2000-07-13 2006-03-07 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US20050075680A1 (en) * 2003-04-18 2005-04-07 Lowry David Warren Methods and systems for intracranial neurostimulation and/or sensing
AU2004261290A1 (en) 2003-08-01 2005-02-10 Northstar Neuroscience, Inc. Apparatus and methods for applying neural stimulation to a patient
US8560041B2 (en) * 2004-10-04 2013-10-15 Braingate Co., Llc Biological interface system
ES2344215T3 (en) 2004-12-07 2010-08-20 Standen Ltd. ELECTRODES TO APPLY A LIVE ELECTRIC FIELD DURING A DILATED TIME PERIOD.
JP5559460B2 (en) 2004-12-27 2014-07-23 スタンデン・リミテッド Method for treating tumors or the like using electric fields of different orientations
US8068892B2 (en) * 2005-06-16 2011-11-29 Aaken Labs Methods and systems for using intracranial electrodes
WO2006138702A2 (en) * 2005-06-16 2006-12-28 Russell Michael J Guided electrical transcranial stimulation (gets) technique
CA2624624C (en) 2005-10-03 2016-07-19 Novocure Limited Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
WO2009044289A1 (en) 2007-03-06 2009-04-09 Novocure Ltd. Treating cancer using electromagnetic fields in combination with photodynamic therapy
CN101820947A (en) 2007-08-14 2010-09-01 诺沃库勒有限公司 Treating parasites with electric fields
US8715203B2 (en) * 2007-09-17 2014-05-06 Novocure Limited Composite electrode
EP2515750A4 (en) * 2009-12-21 2013-07-10 Sherwin Hua INSERTION OF MEDICAL DEVICES ACCORDING TO NON-ORTHOGONAL AND ORTHOGONAL TRACKS WITHIN THE SKULL AND METHODS OF USE
WO2011101039A1 (en) * 2010-02-22 2011-08-25 Universite Pierre Et Marie Curie (Paris 6) Apparatus for the treatment of brain affections and method implementing thereof
JP5746206B2 (en) 2010-11-09 2015-07-08 国立大学法人大阪大学 Implantable device
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US9655669B2 (en) 2013-05-06 2017-05-23 Novocure Limited Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment
US20190117963A1 (en) 2014-07-25 2019-04-25 Loyalty Based Innovations, LLC Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields
CN108136174B (en) 2015-04-17 2022-02-25 穆贾拉医疗私人有限公司 Implantable neurostimulation device
US11058541B2 (en) * 2015-09-04 2021-07-13 The Johns Hopkins University Low-profile intercranial device
US10188851B2 (en) 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
BR112018073648A2 (en) * 2016-05-18 2019-02-19 University Of Iowa Research Foundation cranioplasty plate mounting with support brackets
US10232168B2 (en) * 2016-06-27 2019-03-19 Ecole Polytechnique Federale De Lausanne (Epfl) System for active skull replacement for brain interface and method of using the same
US20180001075A1 (en) 2016-06-30 2018-01-04 Novocure Limited Arrays for Longitudinal Delivery of TTFields to a Body
US20180008708A1 (en) 2016-07-10 2018-01-11 Novocure Limited Synchronizing Tumor Cells to the G2/M Phase Using TTFields Combined with Taxane or Other Anti-Microtubule Agents
CN116747440A (en) * 2016-08-18 2023-09-15 诺沃库勒有限责任公司 Temperature measurement in an array for delivering tumor treatment electric fields
US11577072B2 (en) * 2016-10-19 2023-02-14 Precisis Gmbh Methods and devices for the electrical stimulation of brain tissue via electrodes within cranial bone
DK3554631T3 (en) 2016-12-13 2022-05-30 Novocure Gmbh TREATMENT OF PATIENTS WITH TTFIELDS WITH ELECTRODEPOSITIONS OPTIMIZED USING DEFORMABLE TEMPLATES
WO2018134733A1 (en) 2017-01-19 2018-07-26 Moshe Giladi System for viewing cell cultures under a microscope whilst applying ttfields
PL421532A1 (en) * 2017-05-08 2018-11-19 Michalczyk Marta System for treatment of intracranial neoplasms using an implant, that generates constant, variable electric field and ultrasounds, powered by transdermal energy transfer method
US11338135B2 (en) * 2017-10-23 2022-05-24 Cardiac Pacemakers, Inc. Medical devices for cancer therapy with electric field shaping elements
EP3773726B1 (en) 2018-04-09 2024-06-05 Novocure GmbH Treating tumors with ttfields and an aurora kinase inhibitor
EP3775956B1 (en) 2018-04-10 2022-03-23 Novocure GmbH Low frequency (<1 mhz) ac conductivity estimates derived from two mri images having different repetition times
ES3047748T3 (en) 2018-07-03 2025-12-04 Univ Leland Stanford Junior Using alternating electric fields to increase cell membrane permeability
US11179322B2 (en) 2018-07-10 2021-11-23 Novocure Gmbh Methods and compositions for treating tumors with TTFields and sorafenib
MX2020013431A (en) 2018-07-18 2021-05-27 Novocure Gmbh Using power loss density and related measures to quantify the dose of tumor treating fields (ttfields).
EP3878389B1 (en) 2018-08-23 2025-08-06 Novocure GmbH Using alternating electric fields to increase permeability of the blood brain barrier
US11160977B2 (en) 2018-09-04 2021-11-02 Novocure Gmbh Delivering tumor treating fields (TTFields) to the infratentorial brain
WO2020049482A1 (en) 2018-09-07 2020-03-12 Yaniv Alon Treating autoimmune diseases using an alternating electric field to reduce the proliferation of t-cells
US20200108031A1 (en) 2018-10-05 2020-04-09 Novocure Gmbh Treating Tumors Using TTFields Combined with ABT-751
CN113164525B (en) 2018-10-23 2025-03-14 利兰·斯坦福青年大学托管委员会 Using alternating electric fields in stem cell-based therapy to prevent and treat teratoma formation
JP7148722B2 (en) 2018-10-25 2022-10-05 ゼーヴ・ボンゾン Delivery of an alternating electric field (e.g., TTField) to the spinal structures of a subject
US20200146586A1 (en) 2018-11-14 2020-05-14 Novocure Gmbh Creating Accurate Computational Head Models of Patients Using Datasets Combining MRI and CT Images
IL280843B2 (en) 2018-11-19 2025-10-01 Novocure Gmbh Arrays for delivering tumor treating fields (ttfields) with selectively addressable sub-elements
SG11202101810SA (en) 2018-11-29 2021-03-30 Novocure Gmbh Enhanced-flexibility transducer arrays for delivering ttfields (tumor treating fields)
EP3961565A1 (en) 2019-01-08 2022-03-02 Novocure GmbH Evaluating quality of segmentation of an image into different types of tissue for planning treatment using tumor treating fields (ttfields)
JP7216829B2 (en) 2019-02-22 2023-02-01 ノボキュア ゲーエムベーハー Treatment of gastric cancer using TT fields in combination with XELOX or FOLFOX
IL284284B2 (en) 2019-02-26 2026-03-01 Novocure Gmbh Determining a frequency for ttfields treatment based on an electrical characteristic of targeted cancer cells
EP3954314B1 (en) 2019-02-27 2025-01-08 Novocure GmbH Delivering tumor treating fields (ttfields) using implantable transducer arrays
CN113613651B (en) 2019-03-29 2025-08-12 诺沃库勒有限责任公司 Method for restoring sensitivity to TTField in TTField resistant cancer cells using PTGER3 inhibitors
US11291837B2 (en) 2019-04-17 2022-04-05 Novocure Gmbh Uploading data from an isolated system without compromising isolation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7565205B2 (en) 2000-02-17 2009-07-21 Standen Ltd. Treating a tumor or the like with electric fields at different orientations

Also Published As

Publication number Publication date
CN114364432B (en) 2025-10-31
JP2024091701A (en) 2024-07-05
US20230248969A1 (en) 2023-08-10
JP7472264B2 (en) 2024-04-22
EP4085967A1 (en) 2022-11-09
US20210031031A1 (en) 2021-02-04
EP4085967B1 (en) 2023-09-06
WO2021019403A1 (en) 2021-02-04
US11654279B2 (en) 2023-05-23
EP4003492B1 (en) 2025-06-25
CN121314073A (en) 2026-01-13
EP4085967C0 (en) 2023-09-06
JP2022542400A (en) 2022-10-03
CN114364432A (en) 2022-04-15
EP4003492C0 (en) 2025-06-25
EP4578494A3 (en) 2025-07-30
EP4003492A1 (en) 2022-06-01
US20250360310A1 (en) 2025-11-27

Similar Documents

Publication Publication Date Title
US11654279B2 (en) Applying tumor treating fields (TTFields) via electrodes embedded into skull implants
CA2590342C (en) Electrodes for applying an electric field in-vivo over an extended period of time
CN113747936B (en) Electrodes for electrical stimulation to treat cancer
CN110013606B (en) Implantable lead-in device
US20090254146A1 (en) Deep brain stimulation implant with microcoil array
CN113694371A (en) Implanted electrode and electric field treatment equipment
CN113769267B (en) Implantable electrode capable of monitoring conductivity signal and device for inhibiting cell division
EP3225278A1 (en) Distributed electrode lead configurations and associated systems and methods
CN115501487A (en) Telescopic electrode device
HK40122419A (en) Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
HK40077400A (en) Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
TWI805954B (en) Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
HK40077400B (en) Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
CN112473009A (en) Tumor therapeutic equipment
HK40066188A (en) Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
HK40066188B (en) Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
US20180050213A1 (en) Housing for medical implant
CN121925290A (en) Delivering a tumor therapeutic electric field (TTField) to the brain of a subject using electrodes mounted in through holes in the skull of the subject
CN115253067A (en) Electrode portion of implantable electrode device
KR20240171088A (en) Delivery of tumor therapeutic electric fields (TTFIELD) using grafted graphite sheets
HK1142019B (en) Electrodes for applying an electric field in-vivo over an extended period of time

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AC Divisional application: reference to earlier application

Ref document number: 4003492

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RIC1 Information provided on ipc code assigned before grant

Ipc: A61N 1/40 20060101AFI20250625BHEP

Ipc: A61N 1/36 20060101ALI20250625BHEP

Ipc: A61N 1/05 20060101ALI20250625BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20250810

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40122419

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS